Author name: Simon Carley

Simon Carley MB ChB, PGDip, DipIMC (RCS Ed), FRCS (Ed)(1998), FHEA, FAcadMed, FRCEM, FTACC, MPhil, MD, PhD is Creator, Webmaster, owner and Editor in Chief of the St Emlyn’s blog and podcast. He has a MAHSC Professorship from the University of Manchester. He is a Consultant in adult and paediatric Emergency Medicine at Manchester Foundation Trust and a HEMS consultant with North West Air Ambulance. He is co-founder of BestBets, St.Emlyns and the MSc in emergency medicine at Manchester Metropolitan University. He is an Education Associate with the General Medical Council. His research interests include diagnostics, MedEd, Major incidents & Evidence based Emergency Medicine. He is verified on social media as @EMManchester

tocilizumab

JC: RECOVERY trial shows Tocilizumab effective for COVID19. St Emlyn’s

The first February 2021 report of RECOVERY’s tocilizumab results, written as the announcement and preprint emerged. Simon Carley and Dan Horner outline the reported benefits in hospitalised patients with hypoxia and inflammation, while flagging the need for fuller appraisal and questions about immunosuppression.

JC: RECOVERY trial shows Tocilizumab effective for COVID19. St Emlyn’s Read More

Scroll to Top